<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability</h1>
    <p class="timestamp">Published: 2019-08-07 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of the Agency's annual report entitled "Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments." Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), FDA is required to report annually on the status of postmarketing requirements (PMRs) and postmarketing commitments (PMCs) required of, or agreed upon by, application holders of approved drug and biological p...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-16878</p>
    <p><strong>Publication Date:</strong> 2019-08-07</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/08/07/2019-16878/report-on-the-performance-of-drug-and-biologics-firms-in-conducting-postmarketing-requirements-and">https://www.federalregister.gov/documents/2019/08/07/2019-16878/report-on-the-performance-of-drug-and-biologics-firms-in-conducting-postmarketing-requirements-and</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-16878</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
